AstraZeneca Pharma India Limited (ASTRAZEN.NS) NSE

9,052.50

+9(+0.10%)

Updated at December 30 10:12AM

Currency In INR

AstraZeneca Pharma India Limited

Address

Manyata Embassy Business Park

Bengaluru, 560045

India

Phone

91 80 6774 8000

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Employees

940

First IPO Date

July 01, 2002

Key Executives

NameTitlePayYear Born
Bhavana AgrawalWhole-Time Director & Chief Financial Officer23.24MN/A
Ayush Kumar AgarwalBusiness Unit Head of Biopharmaceutical Business Unit0N/A
Srikanth S.Site Lead, India Operations0N/A
Pankaj S JainLegal Head0N/A
Praveen AkkinepallyMD & Director0N/A
Vinay SharmaBusiness Unit Head - Rare Disease unit0N/A
Amarpreet Kaur AhujaCountry HR Director0N/A
Manasa R.Company Secretary & Compliance Officer0N/A
Smita SahaVice President of Human Resources01970

Description

AstraZeneca Pharma India Limited, a biopharmaceutical company, manufactures, distributes, and markets pharmaceutical products in India and internationally. It manufactures and sells cardiovascular disease and diabetes medicines under the Brilinta, Betaloc, Crestor, Forxiga, Imdur, Kombiglyze XR, Onglyza, Seloken XL, Xigduo XR, and QTERN brands; Respiratory medicines under the Symbicort and FASENRA brand names; and oncology medicines under the LYNPARZA, Tagrisso, Iressa, Calquence, Casodex, Faslodex, Zoladex, and Arimidex brands. The company also offers products in the areas of renal, metabolic, and immunology diseases. It also provides clinical trial services. The company was incorporated in 1979 and is based in Bengaluru, India. AstraZeneca Pharma India Limited is a subsidiary of AstraZeneca Pharmaceuticals AB.